Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others), by and End-User (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027

BIZ4789649
200 Pages
January 2022
Medical Devices

Download Sample Get Discount

Global Neurorehabilitation Market is valued at approximately USD 1097.69 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3 % over the forecast period 2021-2027. Neurorehabilitation is used in Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others. This device is basically used for the treatment of patients with neurological disorders such as in rehabilitation centres, hospitals and clinics. The increasing cases of neurological diseases have led to the adoption of Neurorehabilitation across the forecast period. For Instance: according to the World Health Organization in 2019, the number of neurological diseases is expanding rapidly. WHO states that globally about 264 million people are affected by depression. Bipolar disorders affect about 45 million people globally. 20 million worldwide are affected by schizophrenia. Rising product approvals by regulatory authorities anticipate the growth of Neurorehabilitation Market. Also, with the increasing investment in research and development activities, the adoption & demand for Neurorehabilitation is likely to increase the market growth during the forecast period. However, high device cost impedes the growth of the market over the forecast period of 2021-2027.

The geographical regions considered for the global Neurorehabilitation market analysis includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is deemed as the significant region across the globe in terms of huge market share due to the growing geriatric population and promptness & affordability of neurorehabilitation centers coupled with the well-established healthcare infrastructure and increasing cases of neurological disorders. Whereas, Asia-Pacific is also estimated to attain a maximum growth rate during 2021-2027. Factors such as rising awareness towards neurological disorders, increasing population, rising patient base and improving healthcare infrastructure would create beneficial growth forecasts for the Neurorehabilitation market across Asia-Pacific region.

Major market players included in this report are:

Bionik Laboratories Corp.

BioScience Managers Ltd (Rex Bionics Ltd)

Bioventus (Bioness Inc.)

DIH (Hocoma AG)

Ekso Bionics Holdings, Inc.

Eodyne

Neofect

Neuro Rehab VR

Reha Technology AG

ReWalk Robotics Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Neuro-Robotic Devices

Non-Invasive Stimulators

Brain-Computer Interfaces

By Application:

Brain Stroke

Parkinson's Disease

Multiple Sclerosis

Spinal Cord Injury

Traumatic Brain Injury

Cerebral Palsy

Others

By End User:

Rehabilitation Centers

Hospitals

Clinics

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Neurorehabilitation Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Global Neurorehabilitation Market, by Region, 2019-2027 (USD Billion)

1.2.2. Global Neurorehabilitation Market, by Type, 2019-2027 (USD Billion)

1.2.3. Global Neurorehabilitation Market, by Application, 2019-2027 (USD Billion)

1.2.4. Global Neurorehabilitation Market, by End User, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Neurorehabilitation Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Neurorehabilitation Market Dynamics

3.1. Neurorehabilitation Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing cases of neurological diseases

3.1.1.2. Rising product approvals by regulatory authorities

3.1.2. Market Challenges

3.1.2.1. High device cost

3.1.3. Market Opportunities

3.1.3.1. Increasing investment in research and development activities

Chapter 4. Global Neurorehabilitation Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Neurorehabilitation Market, by Type

6.1. Market Snapshot

6.2. Global Neurorehabilitation Market by Type, Performance - Potential Analysis

6.3. Global Neurorehabilitation Market Estimates & Forecasts by Type, 2018-2027 (USD Billion)

6.4. Neurorehabilitation Market, Sub Segment Analysis

6.4.1. Neuro-Robotic Devices

6.4.2. Non-Invasive Stimulators

6.4.3. Brain-Computer Interfaces

Chapter 7. Global Neurorehabilitation Market, by Application

7.1. Market Snapshot

7.2. Global Neurorehabilitation Market by Application, Performance - Potential Analysis

7.3. Global Neurorehabilitation Market Estimates & Forecasts by Application, 2018-2027 (USD Billion)

7.4. Neurorehabilitation Market, Sub Segment Analysis

7.4.1. Brain Stroke

7.4.2. Parkinson's Disease

7.4.3. Multiple Sclerosis

7.4.4. Spinal Cord Injury

7.4.5. Traumatic Brain Injury

7.4.6. Cerebral Palsy

7.4.7. Others

Chapter 8. Global Neurorehabilitation Market, by End User

8.1. Market Snapshot

8.2. Global Neurorehabilitation Market by End User, Performance - Potential Analysis

8.3. Global Neurorehabilitation Market Estimates & Forecasts by End User, 2018-2027 (USD Billion)

8.4. Neurorehabilitation Market, Sub Segment Analysis

8.4.1. Rehabilitation Centers

8.4.2. Hospitals

8.4.3. Clinics

Chapter 9. Global Neurorehabilitation Market, Regional Analysis

9.1. Neurorehabilitation Market, Regional Market Snapshot

9.2. North America Neurorehabilitation Market

9.2.1. U.S. Neurorehabilitation Market

9.2.1.1. Type breakdown estimates & forecasts, 2018-2027

9.2.1.2. Application breakdown estimates & forecasts, 2018-2027

9.2.1.3. End User breakdown estimates & forecasts, 2018-2027

9.2.2. Canada Neurorehabilitation Market

9.3. Europe Neurorehabilitation Market Snapshot

9.3.1. U.K. Neurorehabilitation Market

9.3.2. Germany Neurorehabilitation Market

9.3.3. France Neurorehabilitation Market

9.3.4. Spain Neurorehabilitation Market

9.3.5. Italy Neurorehabilitation Market

9.3.6. Rest of Europe Neurorehabilitation Market

9.4. Asia-Pacific Neurorehabilitation Market Snapshot

9.4.1. China Neurorehabilitation Market

9.4.2. India Neurorehabilitation Market

9.4.3. Japan Neurorehabilitation Market

9.4.4. Australia Neurorehabilitation Market

9.4.5. South Korea Neurorehabilitation Market

9.4.6. Rest of Asia Pacific Neurorehabilitation Market

9.5. Latin America Neurorehabilitation Market Snapshot

9.5.1. Brazil Neurorehabilitation Market

9.5.2. Mexico Neurorehabilitation Market

9.6. Rest of The World Neurorehabilitation Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Bionik Laboratories Corp.,

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. BioScience Managers Ltd (Rex Bionics Ltd)

10.2.3. Bioventus (Bioness Inc.)

10.2.4. DIH (Hocoma AG)

10.2.5. Ekso Bionics Holdings, Inc.

10.2.6. Eodyne

10.2.7. Neofect

10.2.8. Neuro Rehab VR

10.2.9. Reha Technology AG

10.2.10. ReWalk Robotics Ltd.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Neurorehabilitation market, report scope

TABLE 2. Global Neurorehabilitation market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Neurorehabilitation market estimates & forecasts by Type 2018-2027 (USD Billion)

TABLE 4. Global Neurorehabilitation market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 5. Global Neurorehabilitation market estimates & forecasts by End User 2018-2027 (USD Billion)

TABLE 6. Global Neurorehabilitation market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Neurorehabilitation market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Neurorehabilitation market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Neurorehabilitation market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Neurorehabilitation market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Neurorehabilitation market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Neurorehabilitation market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Neurorehabilitation market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Neurorehabilitation market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Neurorehabilitation market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. U.S. Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. U.S. Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. Canada Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Canada Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. Canada Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. UK Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 23. UK Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. UK Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Germany Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 26. Germany Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Germany Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. RoE Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 29. RoE Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. RoE Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. China Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 32. China Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. China Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. India Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 35. India Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. India Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Japan Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 38. Japan Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Japan Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. RoAPAC Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 41. RoAPAC Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. RoAPAC Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Brazil Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 44. Brazil Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Brazil Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Mexico Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 47. Mexico Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Mexico Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. RoLA Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 50. RoLA Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. RoLA Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Row Neurorehabilitation market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 53. Row Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Row Neurorehabilitation market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. List of secondary sources, used in the study of global Neurorehabilitation market

TABLE 56. List of primary sources, used in the study of global Neurorehabilitation market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara